Rep. Kevin Hern sold Novo Nordisk A/S (NVO)
Rep. Kevin Hern (R-OK-1) · $1K–$15K · traded Sep 10, 2026
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Sep 10, 2026
- Disclosed
- Sep 28, 2026
- Days to disclose
- 18
- Asset type
- Stock
- As filed
- Novo Nordisk A/S
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
All of Hern's trades →- Sep 28, 2026$1K–$15K
$1K–$15K · Traded Sep 15, 2026 · disclosed Sep 28, 2026
- Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 15, 2026 · disclosed Sep 28, 2026
- Sep 28, 2026$1K–$15K
Sold Seagate Technology Holdings STX
$1K–$15K · Traded Sep 15, 2026 · disclosed Sep 28, 2026
- Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 15, 2026 · disclosed Sep 28, 2026
- Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$1K–$15K
$1K–$15K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$15K–$50K
Sold Virtus Artificial Intelligence & Technology Opportunities Fund AIO
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$1K–$15K
Sold Marsh & McLennan Companies MRSH
$1K–$15K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$1K–$15K
$1K–$15K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$15K–$50K
Sold Cadence Design Systems CDNS
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$100K–$250K
$100K–$250K · Traded Sep 11, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$500K–$1M
$500K–$1M · Traded Sep 11, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 10, 2026 · disclosed Sep 28, 2026 · Joint
Committee overlap: Ways and Means - Sep 28, 2026$15K–$50K
$15K–$50K · Traded Sep 10, 2026 · disclosed Sep 28, 2026 · Joint
- Sep 28, 2026$1K–$15K
$1K–$15K · Traded Sep 10, 2026 · disclosed Sep 28, 2026
Recent Congress trades in NVO
- Sep 28, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Aug 31, 2026 · disclosed Sep 28, 2026
- Sep 18, 2026$1K–$15K
Rep. Scott Franklin (R-FL-18)
$1K–$15K · Traded Aug 26, 2026 · disclosed Sep 18, 2026
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 30, 2026 · disclosed Jul 21, 2026 · filed 113 days later
Committee overlap: HELP - Nov 24, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Sold (full) Novo Nordisk A/S NVO
$1K–$15K · Traded Oct 31, 2025 · disclosed Nov 24, 2025 · Spouse
- Nov 24, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Sold (full) Novo Nordisk A/S NVO
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 24, 2025 · Spouse
- Nov 24, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 24, 2025 · Spouse
- Oct 22, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Sep 11, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 21, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Oct 15, 2025 · disclosed Oct 21, 2025
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.